Viking Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Hold |
318,700
| – | – | 2.03% | 6 |
|
|
2025
Q1 | $19.4M | Buy |
318,700
+100,000
| +46% | +$6.1M | 2.8% | 4 |
|
|
2024
Q4 | $12.4M | Buy |
218,700
+125,100
| +134% | +$7.08M | 1.93% | 7 |
|
|
2024
Q3 | $4.84M | Sell |
93,600
-19,100
| -17% | -$988K | 0.79% | 49 |
|
|
2024
Q2 | $4.68M | Buy |
112,700
+10,000
| +10% | +$415K | 0.84% | 45 |
|
|
2024
Q1 | $5.57M | Buy |
102,700
+2,700
| +3% | +$146K | 1.01% | 32 |
|
|
2023
Q4 | $5.13M | Buy |
100,000
+12,000
| +14% | +$616K | 1% | 35 |
|
|
2023
Q3 | $5.11M | Buy |
88,000
+10,000
| +13% | +$580K | 1.03% | 37 |
|
|
2023
Q2 | $4.99M | Buy |
78,000
+5,000
| +7% | +$320K | 0.94% | 43 |
|
|
2023
Q1 | $5.06M | Buy |
73,000
+33,000
| +83% | +$2.29M | 0.97% | 36 |
|
|
2022
Q4 | $2.88M | Buy |
+40,000
| New | +$2.88M | 0.57% | 66 |
|
|
2021
Q1 | – | Sell |
-5,000
| Closed | -$310K | – | 122 |
|
|
2020
Q4 | $310K | Sell |
5,000
-35,000
| -88% | -$2.17M | 0.1% | 111 |
|
|
2020
Q3 | $2.41M | Sell |
40,000
-25,000
| -38% | -$1.51M | 0.9% | 38 |
|
|
2020
Q2 | $3.82M | Buy |
65,000
+13,000
| +25% | +$764K | 1.41% | 24 |
|
|
2020
Q1 | $2.9M | Buy |
52,000
+7,000
| +16% | +$390K | 1.27% | 30 |
|
|
2019
Q4 | $2.89M | Buy |
45,000
+13,000
| +41% | +$835K | 0.81% | 47 |
|
|
2019
Q3 | $1.62M | Buy |
+32,000
| New | +$1.62M | 0.46% | 64 |
|